CSS
IDXX icon

Cubist Systematic Strategies’s Idexx Laboratories IDXX Stock Holding History

Cubist Systematic Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,090
Closed -$4.43M – 3239
2024
Q3 		$5.1M Buy
+10,090
New +$4.9M 0.03% 824
2024
Q2 		– Sell
-21,351
Closed -$10.7M – 3460
2024
Q1 		$11.5M Buy
+21,351
New +$11.7M 0.07% 431
2023
Q4 		– Sell
-8,102
Closed -$3.8M – 3815
2023
Q3 		$3.54M Sell
8,102
-4,579
-36% -$2.28M 0.03% 973
2023
Q2 		$6.37M Sell
12,681
-8,473
-40% -$4.06M 0.04% 695
2023
Q1 		$10.6M Buy
21,154
+18,777
+790% +$8.99M 0.06% 429
2022
Q4 		$970K Sell
2,377
-11,643
-83% -$4.52M 0.01% 2478
2022
Q3 		$4.57M Sell
14,020
-8,518
-38% -$3.13M 0.03% 1160
2022
Q2 		$7.91M Buy
22,538
+11,449
+103% +$4.67M 0.05% 617
2022
Q1 		$6.07M Buy
11,089
+9,787
+752% +$5.15M 0.05% 580
2021
Q4 		$857K Sell
1,302
-7,180
-85% -$4.51M 0.01% 2034
2021
Q3 		$5.28M Buy
8,482
+4,026
+90% +$2.71M 0.07% 441
2021
Q2 		$2.81M Sell
4,456
-18,535
-81% -$10.2M 0.03% 870
2021
Q1 		$11.3M Buy
22,991
+22,039
+2,315% +$11M 0.14% 132
2020
Q4 		$476K Sell
952
-19,201
-95% -$8.59M 0.01% 1796
2020
Q3 		$7.92M Buy
20,153
+17,589
+686% +$6.5M 0.12% 219
2020
Q2 		$847K Buy
2,564
+634
+33% +$184K 0.01% 1284
2020
Q1 		$468K Sell
1,930
-15,219
-89% -$3.97M 0.01% 1288
2019
Q4 		$4.48M Buy
17,149
+14,976
+689% +$3.95M 0.08% 352
2019
Q3 		$591K Sell
2,173
-7,424
-77% -$2.07M 0.01% 1213
2019
Q2 		$2.64M Buy
9,597
+6,589
+219% +$1.62M 0.05% 556
2019
Q1 		$673K Sell
3,008
-8,561
-74% -$1.77M 0.02% 994
2018
Q4 		$2.15M Buy
11,569
+5,998
+108% +$1.23M 0.1% 249
2018
Q3 		$1.39M Buy
5,571
+1,651
+42% +$401K 0.08% 333
2018
Q2 		$854K Sell
3,920
-7,205
-65% -$1.48M 0.04% 547
2018
Q1 		$2.13M Buy
11,125
+4,677
+73% +$863K 0.12% 204
2017
Q4 		$1.01M Sell
6,448
-1,214
-16% -$191K 0.05% 472
2017
Q3 		$1.19M Buy
7,662
+384
+5% +$60.7K 0.07% 343
2017
Q2 		$1.18M Buy
7,278
+5,415
+291% +$879K 0.08% 364
2017
Q1 		$288K Sell
1,863
-7,203
-79% -$993K 0.02% 943
2016
Q4 		$1.06M Sell
9,066
-7,536
-45% -$860K 0.08% 349
2016
Q3 		$1.87M Buy
16,602
+1,815
+12% +$191K 0.12% 220
2016
Q2 		$1.37M Buy
14,787
+3,500
+31% +$301K 0.08% 322
2016
Q1 		$884K Buy
+11,287
New +$813K 0.05% 508
2015
Q3 		– Sell
-11,739
Closed -$753K – 1922
2015
Q2 		$753K Buy
11,739
+6,539
+126% +$453K 0.04% 732
2015
Q1 		$402K Sell
5,200
-104
-2% -$8.09K 0.02% 1072
2014
Q4 		$393K Sell
5,304
-18,832
-78% -$1.32M 0.02% 1021
2014
Q3 		$1.42M Buy
24,136
+22,536
+1,409% +$1.42M 0.09% 313
2014
Q2 		$107K Buy
+1,600
New +$102K 0.01% 1313

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Cubist Systematic Strategies's IDXX Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 10,090 shares — an estimated $4.43M sold.

Cubist Systematic Strategies first reported a position in IDXX in Q2 2014 and held it in 38 quarters. The position peaked at $11.5M in Q1 2024. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 10,090 Idexx Laboratories shares in Q4 2024, an estimated $4.43M.
  • Cubist Systematic Strategies first reported a position in Idexx Laboratories in Q2 2014 and held it in 38 quarters.
  • Cubist Systematic Strategies's Idexx Laboratories position peaked at $11.5M in Q1 2024.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.